PD-L1 Pathway Markers and Chromosome 9p24.1 Alterations in Patients with Classic Hodgkin Lymphoma Treated with Frontline Single Agent Pembrolizumab (PEM) Followed By AVD Chemotherapy

被引：0
|
作者：
Allen, Pamela B.
Lu, Xinyan
Chen, Qing C.
Slonim, Liron Barnea
Sukhanova, Madina
Savas, Hatice
Chmiel, Joan
O'Shea, Kaitlyn
Evens, Andrew M.
Advani, Ranjana
Pro, Barbara
Karmali, Reem
Palmer, Brett Alan
Bearden, Jeffrey
Mou, Eric
Dillehay, Gary
Gordon, Leo I.
Winter, Jane N.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-139816
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 8 条
  • [1] Extended Follow up and Immune Alterations in Patients with Classic Hodgkin Lymphoma (cHL) Treated with Frontline Single Agent Pembrolizumab Followed By AVD Chemotherapy
    Allen, Pamela B.
    Bazzi, Latifa
    Zhang, Bin
    Chen, Qing
    Slonim, Liron Barnea
    Savas, Hatice
    Advani, Ranjana H.
    Evens, Andrew M.
    Pro, Barbara
    Karmali, Reem
    Mou, Eric
    Eisner, Robert
    Bayer, Robert
    Gordon, Leo I.
    Winter, Jane N.
    BLOOD, 2024, 144 : 1664 - 1665
  • [2] Frontline Treatment with Single Agent Pembrolizumab (PEM) Followed By AVD Chemotherapy for Classic Hodgkin Lymphoma: Updated Results and Correlative Analysis
    Allen, Pamela
    Chen, Qing C.
    Lu, Xinyan
    O'Shea, Kaitlyn
    Chmiel, Joan
    Sukhanova, Madina
    Slonim, Liron Barnea
    Savas, Hatice
    Mou, Eric
    Pro, Barbara
    Evens, Andrew M.
    Palmer, Brett Alan
    Advani, Ranjana
    Gordon, Leo I.
    Winter, Jane N.
    BLOOD, 2021, 138
  • [3] Chromosome 9p24.1/PD-L1/PD-L2Alterations and PD-L1 Expression and Treatment Outcomes in Patients with Classical Hodgkin Lymphoma Treated with Nivolumab (PD-1 Blockade)
    Roemer, Margaretha G. M.
    Ligon, Azra H.
    Engert, Andreas
    Younes, Anas
    Santoro, Armando
    Zinzani, Pier Luigi
    Timmerman, John M.
    Ansell, Stephen
    Armand, Philippe
    Fanale, Michelle A.
    Ratanatharathorn, Voravit
    Kuruvilla, John
    Cohen, Jonathon B.
    Collins, Graham P.
    Savage, Kerry J.
    Trneny, Marek
    Neuberg, Donna S.
    Redd, Robert A.
    Farsaci, Benedetto
    Kato, Kazunobu
    Sumbul, Anne
    Rodig, Scott J.
    Shipp, Margaret A.
    BLOOD, 2016, 128 (22)
  • [4] PD-L1 expression in pediatric Epstein-Barr virus positive classic Hodgkin lymphoma is not associated with 9p24.1 amplification
    Uccini, Stefania
    Al-Jadiry, Mazin F.
    Pepe, Giuseppina
    Scarpino, Stefania
    Al-Hadad, Salma A.
    Ruco, Luigi
    PEDIATRIC BLOOD & CANCER, 2019, 66 (07)
  • [5] Immune Checkpoint Molecule (PD-1, PD-L1, PD-L2) Expression, 9p24.1 Gene Locus Alterations and Tumor Microenvironment Status of Primary Central Nervous System Lymphoma and Their Clinical Relevance: A Quantitative Analysis
    Akbulut, Dilara
    Yuksel, Seher
    Kircali, Ekin
    Aktas, Burak Yasin
    Kaygusuz, Gulsah
    Saglam, Arzu
    Soylemezoglu, Figen
    Uner, Aysegul
    Ozcan, Muhit
    Turker, Alev
    Kuzu, Isinsu
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 796 - 797
  • [6] Immune Checkpoint Molecule (PD-1, PD-L1, PD-L2) Expression, 9p24.1 Gene Locus Alterations and Tumor Microenvironment Status of Primary Central Nervous System Lymphoma and Their Clinical Relevance: A Quantitative Analysis
    Akbulut, Dilara
    Yuksel, Seher
    Kircali, Ekin
    Aktas, Burak Yasin
    Kaygusuz, Gulsah
    Saglam, Arzu
    Soylemezoglu, Figen
    Uner, Aysegul
    Ozcan, Muhit
    Turker, Alev
    Kuzu, Isinsu
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 796 - 797
  • [7] Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study)
    Makita, Shinichi
    Kusumoto, Shigeru
    Tamaru, Jun-Ichi
    Hashimoto, Hiroya
    Maeshima, Akiko Miyagi
    Uchida, Toshiki
    Tsujimura, Hideki
    Ohtsuka, Eiichi
    Takayama, Nobuyuki
    Murayama, Kayoko
    Takahashi, Naoki
    Yoshida, Masahiro
    Morimoto, Hiroaki
    Suzuki, Yasuhiro
    Shimada, Kazuyuki
    Makita, Masanori
    Ota, Shuichi
    Gomyo, Hiroshi
    Takahashi, Hiroyuki
    Suzuki, Ritsuro
    Katsuya, Hiroo
    Tatetsu, Hiro
    Momose, Shuji
    Yamashita, Takahisa
    Ohsawa, Kumiko
    Asano, Naoko
    Maruyama, Dai
    Yamaguchi, Motoko
    Nagai, Hirokazu
    BLOOD, 2022, 140 : 11890 - 11892
  • [8] 9p24.1 Genetic Alteration and PD-L1 Expression Are Characteristic of De Novo and Methotrexate-associated Epstein-Barr Virus-positive Hodgkin Lymphoma, But Not Methotrexate-associated Hodgkin-like Lesions
    Shiraiwa, Sawako
    Kikuti, Yara Yukie
    Carreras, Joaquim
    Kondo, Yusuke
    Ohmachi, Ken
    Ogawa, Yoshiaki
    Kawada, Hiroshi
    Sato, Shinji
    Gion, Yuka
    Sato, Yasuharu
    Nakamura, Naoya
    Ando, Kiyoshi
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2022, 46 (08) : 1017 - 1024
1